311 related articles for article (PubMed ID: 36571611)
1. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
3. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
4. Topical cetirizine for treating androgenetic alopecia: A systematic review.
Chen X; Xiang H; Yang M
J Cosmet Dermatol; 2022 Nov; 21(11):5519-5526. PubMed ID: 35976065
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
Ghonemy S; Alarawi A; Bessar H
J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Rossi A; Campo D; Fortuna MC; Garelli V; Pranteda G; De Vita G; Sorriso-Valvo L; Di Nunno D; Carlesimo M
J Dermatolog Treat; 2018 Mar; 29(2):149-151. PubMed ID: 28604133
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of topical cetirizine 1% in treatment of male androgenetic alopecia: A case-controlled study.
Zaky MS; Abo Khodeir H; Ahmed HA; Elsaie ML
J Cosmet Dermatol; 2021 Apr; 20(4):1154-1159. PubMed ID: 33417284
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
9. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
11. Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia.
Wei W; Zhang Y; Long B; Zhang Y; Zhang C; Zhang S
Skin Res Technol; 2023 Jul; 29(7):e13315. PubMed ID: 37522500
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
Asilian A; Farmani A; Saber M
J Cosmet Dermatol; 2024 Mar; 23(3):949-957. PubMed ID: 38031516
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
16. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
18. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial.
Kanti V; Hillmann K; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1183-9. PubMed ID: 26387973
[TBL] [Abstract][Full Text] [Related]
19. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia.
Kumar MK; Inamadar AC; Palit A
J Cutan Aesthet Surg; 2018; 11(4):211-216. PubMed ID: 30886475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
